Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

223- 227


Authors Details

Shray Dogra, Gursatinder Singh, Anita K Gupta, Dharamvir Chalia, Navneet Kaur


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 2030

PDF Downloaded: 1423


The intraocular pressure lowering efficacy of 0.5% timolol maleate versus 1% brinzolamide in cases of primary open angle glaucoma and ocular hypertension


Original Article

Author Details : Shray Dogra, Gursatinder Singh, Anita K Gupta, Dharamvir Chalia, Navneet Kaur

Volume : 1, Issue : 4, Year : 2015

Article Page : 223-227


Suggest article by email

Get Permission

Abstract

Objectives: The aim of this study was to compare the intraocular pressure lowering efficacy of timolol maleate with brinzolamide in cases of primary open angle glaucoma and ocular hypertension.
Methods and Materials: This prospective, open, randomized, parallel group, comparative study was conducted in patients coming to the Department Of Ophthalmology, Rajindra Hospital attached to Government Medical College, Patiala. 60 patients of POAG or ocular hypertension were selected. Patients were then randomized into two groups (group I, II) and received 0.5 % timolol maleate and 1% brinzolamide respectively. Effectiveness of the drugs was calculated in terms of mm Hg fall in mean intraocular pressure at the end of 3 months. The observations thus made in both groups were compared.
Results: In group I the mean pre-treatment IOP, mean post-treatment IOP and mean reduction in IOP were 24.30 ± 0.99, 18.53 ± 1.22 and 5.77 (23.74%) for peak measurements, and 24.50 ± 1.08, 18.80 ± 1.22 and 5.70 (23.27%) for trough measurements. In group II the mean pre-treatment IOP, mean post-treatment IOP and mean reduction in IOP were 24.33 ± 0.96, 19.43 ± 1.14 and 4.90 (20.14%) for peak measurements, and 24.57 ± 0.97, 19.73 ± 1.11 and 4.84 (19.69%) for trough measurements.
Conclusions: In conclusion, there was a statistically significant difference between the IOP lowering in the two groups with timolol maleate producing more reduction in IOP than brinzolamide.

Key-words: Brinzolamide; Glaucoma; lOP; Ocular hypertension; POAG; Timolol.


How to cite : Dogra S, Singh G, Gupta A K, Chalia D, Kaur N, The intraocular pressure lowering efficacy of 0.5% timolol maleate versus 1% brinzolamide in cases of primary open angle glaucoma and ocular hypertension. Indian J Clin Exp Ophthalmol 2015;1(4):223-227

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.